graft
-
Sports Medicine
Smith+Nephew Sports Medicine advances procedural innovation by launching the QUADTRAC™ Quadriceps Tendon Harvest Guide System and expanded family of ULTRABUTTON™ Adjustable Fixation Devices for ACL reconstruction
LONDON, March 7, 2023 /PRNewswire/ — Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today introduced the UltraTRAC™ QUAD ACL Reconstruction Technique which consists…
Read More » -
Spine
TheraCell Announces Immediate Release Of Its TheraFuze DBF® Fiber Bag Solution For Graft Containment In Spinal Surgery
LOS ANGELES, March 2, 2021 /PRNewswire/ — TheraCell Inc., a leading allograft solution company, today announced that its newest procedure-specific fiber graft form, the TheraFuze…
Read More » -
Biologics
Cerapedics Announces Commercial Launch of i-FACTOR®+ Matrix in Canada
Canada will be the first commercial market to launch i-FACTOR®+ Matrix WESTMINSTER, Colo., Nov. 5, 2020 /PRNewswire/ — Cerapedics, a private ortho-biologics company, today…
Read More » -
Financial
Artoss, Inc. Announces Record Sales of NanoBone® Bone Graft
Press Release October 5, 2020 Artoss, Inc. is pleased to announce that it achieved record sales of NanoBone Bone Graft…
Read More » -
Biologics
Spine Wave Announces the Commercial Launch of Tornado® Bioactive Bone Graft Matrix
SHELTON, Conn., Sept. 24, 2020 (GLOBE NEWSWIRE) — Spine Wave is pleased to announce the commercial launch of Tornado® Bioactive Bone…
Read More » -
Biologics
Bioventus Reports First Use of its SIGNAFUSE® Bioactive Bone Graft in Strip Format
September 2, 2020 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus is sharing results of its first in-patient use of the new SIGNAFUSE Bioactive Bone Graft strips. Rick…
Read More » -
Biologics
Xtant Medical Announces U.S. Commercial Launch of the Matriform® Si for Spinal Fusion Procedures
BELGRADE, Mont., Aug. 24, 2020 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company…
Read More » -
Biologics
Baxter Announces U.S. FDA Clearance of Altapore Shape Bioactive Bone Graft for Use in Surgery
July 9, 2020 DEERFIELD, Ill.–(BUSINESS WIRE)–Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced U.S. Food…
Read More » -
Biologics
Bioventus Receives FDA Clearance of Strip Format of its SIGNAFUSE® Bioactive Bone Graft
June 25, 2020 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologic solutions, is launching its SIGNAFUSE Bioactive Bone Graft in a new…
Read More » -
Biologics
Biogennix Remains Operational as it Prepares for Post-Coronavirus Surgical Demand
IRVINE, Calif. — April 14, 2020 — Irvine-based Biogennix, an osteobiologics company that develops, manufactures, and distributes proprietary bone graft…
Read More » -
Biologics
BBS-Bioactive Bone Substitutes Plc: We are pleased to announce that the clinical result of ARTEBONE® is positive yielding an outcome similar to patient’s own bone graft
19.2.2020 The clinical investigation run by BBS-Bioactive Bone Substitutes Oyj in clinical centers in Finland and Poland has been finalized…
Read More » -
Hospitals
UK based medical device company announces two new patents granted by the US Patent and Trademark Office
SIRAKOSS Ltd., a UK-based medical device company developing innovative bone grafting solutions for the $3 billion global orthopaedic market, has…
Read More »